Twist Bioscience Corporation (TWST)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS90184D1000
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Twist Bioscience Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 14:12. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 03 Aug 2026 07:00 | -0.28 | -0.56 | -98.5% | Miss |
| 04 May 2026 07:00 | -0.53 | -0.60 | -12.6% | Miss |
| 02 Feb 2026 07:00 | -0.52 | -0.50 | +3.9% | Beat |
| 14 Nov 2025 07:00 | -0.50 | -0.45 | +10.0% | Beat |
| 04 Aug 2025 07:00 | -0.57 | -0.47 | +18.1% | Beat |
| 05 May 2025 07:00 | -0.56 | -0.66 | -17.4% | Miss |
| 03 Feb 2025 07:00 | -0.63 | -0.53 | +16.5% | Beat |
| 18 Nov 2024 07:00 | -0.69 | -0.59 | +14.9% | Beat |
| 02 Aug 2024 07:00 | -0.77 | -0.70 | +8.8% | Beat |
| 02 May 2024 16:00 | -0.81 | -0.79 | +3.1% | Beat |
| 02 Feb 2024 07:00 | -0.77 | -0.75 | +2.6% | Beat |
| 17 Nov 2023 07:00 | -0.86 | -0.75 | +13.2% | Beat |
| 04 Aug 2023 07:00 | -1.06 | -1.02 | +4.6% | Beat |
| 05 May 2023 07:00 | -1.10 | -1.06 | +3.4% | Beat |
| 03 Feb 2023 07:00 | -1.17 | -0.81 | +30.4% | Beat |
| 18 Nov 2022 07:00 | -1.13 | -1.01 | +10.9% | Beat |
| 05 Aug 2022 07:00 | -1.31 | -1.08 | +17.4% | Beat |
| 05 May 2022 16:00 | -1.30 | -1.02 | +21.6% | Beat |
| 04 Feb 2022 07:00 | -1.06 | -0.96 | +9.5% | Beat |
| 22 Nov 2021 07:00 | -0.80 | -0.88 | -9.9% | Miss |
| 06 Aug 2021 07:00 | -0.75 | -0.78 | -4.1% | Miss |
| 06 May 2021 16:00 | -0.78 | -0.78 | +0.6% | In line |
| 04 Feb 2021 16:00 | -0.77 | -0.72 | +7.1% | Beat |
| 23 Nov 2020 07:00 | -0.71 | -0.54 | +24.3% | Beat |
| 06 Aug 2020 16:00 | -0.88 | -0.67 | +23.9% | Beat |
| 07 May 2020 17:00 | -0.75 | -0.85 | -13.3% | Miss |
| 06 Feb 2020 16:00 | -0.83 | -1.00 | -20.2% | Miss |
| 11 Dec 2019 16:00 | -0.84 | -0.96 | -14.8% | Miss |
| 01 Aug 2019 16:00 | -0.82 | -0.92 | -12.7% | Miss |
| 30 Apr 2019 16:00 | -0.97 | -0.93 | +3.8% | Beat |
| 07 Feb 2019 16:00 | -0.85 | -1.18 | -39.2% | Miss |
| 19 Dec 2018 16:00 | -0.67 | -0.66 | +2.3% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 376.6M | +20.3% | -77.7M | -20.6% | -1.30 | +63.9% | -75.6M |
| 2024 | 313M | +27.7% | -208.7M | -66.7% | -3.60 | 0.0% | -69.2M |
| 2023 | 245.1M | +20.4% | -204.6M | -83.5% | -3.60 | +10.9% | -170.3M |
| 2022 | 203.6M | — | -217.9M | -107.0% | -4.04 | — | -226.2M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 12 Nov 2026 In progress | 123.80 | 151.50 | 93.68 | 114.22 | -5.44% | 12,168,500 | |
| 02 Nov 2026 – 06 Nov 2026 | 153.17 | 154.23 | 116.50 | 120.79 | -20.94% | 11,759,800 | |
| 26 Oct 2026 – 30 Oct 2026 | 139.45 | 178.53 | 136.19 | 152.78 | +9.19% | 11,797,200 | |
| 19 Oct 2026 – 23 Oct 2026 | 136.99 | 153.80 | 131.23 | 139.92 | +5.40% | 10,792,900 | |
| 12 Oct 2026 – 16 Oct 2026 | 159.78 | 161.80 | 130.68 | 132.75 | -16.92% | 12,663,200 | |
| 05 Oct 2026 – 09 Oct 2026 | 193.46 | 219.71 | 144.60 | 159.78 | -15.31% | 25,571,500 | |
| 28 Sep 2026 – 02 Oct 2026 | 181.82 | 200.31 | 175.02 | 188.67 | +3.19% | 14,324,900 | |
| 21 Sep 2026 – 25 Sep 2026 | 168.40 | 186.20 | 156.83 | 182.83 | +9.49% | 12,922,300 | |
| 14 Sep 2026 – 18 Sep 2026 | 126.04 | 167.05 | 121.92 | 166.99 | +31.26% | 11,941,500 | |
| 08 Sep 2026 – 11 Sep 2026 | 121.38 | 131.60 | 120.19 | 127.22 | +2.00% | 6,034,100 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Twist Bioscience Corporation Q4 2026 Earnings Call Summary (opens in a new tab) Moby · 12 Nov 2026 22:15
- This Biotech's Guidance Seemingly Beat Expectations — But A Twist Slammed The Stock (opens in a new tab) Investor's Business Daily · 12 Nov 2026 21:16
- Twist Bioscience Q4 Earnings Call Highlights (opens in a new tab) MarketBeat · 12 Nov 2026 21:14
- Twist Bioscience: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 12 Nov 2026 21:09
- Twist Bioscience earnings analysis: questions answered and next catalysts (opens in a new tab) Investing.com · 12 Nov 2026 20:59
- Twist Bioscience (TWST) Q4 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 12 Nov 2026 19:45
- Full-Year Revenue Guidance and Strong Quarter Drove Twist Bioscience Corporation (TWST) Higher in Q3 (opens in a new tab) Insider Monkey · 12 Nov 2026 15:07
- Twist Bioscience Corporation (TWST) Q4 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 12 Nov 2026 13:49
- Twist Bioscience: Fiscal Q4 Earnings Snapshot (opens in a new tab) Associated Press · 12 Nov 2026 13:40
- Twist Bioscience (TWST) Reports Q4 Loss, Beats Revenue Estimates (opens in a new tab) Zacks · 12 Nov 2026 13:35
- Twist Bioscience Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results (opens in a new tab) 12 Nov 2026 12:15
- Twist Bioscience Q4 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 12 Nov 2026 10:23
- Twist Bioscience Q4 EPS $(0.32) Beats $(0.34) Estimate, Sales $126.644M Beat $123.085M Estimate (opens in a new tab) Benzinga · 12 Nov 2026 08:24
- Twist Bioscience Sees FY2027 Sales $550.000M-$560.000M vs $547.137M Est (opens in a new tab) Benzinga · 12 Nov 2026 08:18
- Twist Bioscience Sees Q1 Sales $130.000M-$132.000M vs $126.354M Est (opens in a new tab) Benzinga · 12 Nov 2026 08:18
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 122.59 USD
- Market cap
- 7.6B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow TWST and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.